E2F1 and hepatocellular carcinoma: A similar study found that miR‐384 inhibited the malignant progression of glioma by inhibiting PIWIL4 expression by targeting its 3′‐UTR region [26], while miR‐331‐3p downregulated E2F1 expression and promoted the proliferation and migration of hepatoma cells [59].